Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Corey

Showing results (31-40 of 173) with videos related to

Pageof 18
Sort By:
Revista Da Sociedade Brasileira De Medicina Tropical|February 22, 2005
[Evaluation of a rapid test using recombinant k39 antigen in the diagnosis of visceral leishmaniasis in Brazil ]Elenice Moreira Lemos, Silvio F Guimarães Carvalho, Ralph Corey, et al.
The New England Journal of Medicine|March 7, 2008
Clinical problem-solving. A key miscommunication--an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomitingMelissa H Kong, G Ralph Corey, Thomas Bashore, et al.
Expert Opinion on Pharmacotherapy|November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumoniaEthan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
Diagnostic Microbiology and Infectious Disease|July 23, 2013
Diagnostic dilemma in a returning traveler with feverJelena Catania, Seth S Martin, G Ralph Corey, et al.
The American Journal of Tropical Medicine and Hygiene|April 11, 2003
Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasisSilvio F Guimarães Carvalho, Elenice Moreira Lemos, Ralph Corey, et al.
American Heart Journal|April 13, 2004
Novel approaches to clinical trials: device-related infectionsRobert M Califf, Vance Fowler, Christopher H Cabell, et al.
The Lancet. Infectious Diseases|March 27, 2015
A closer inspection of tedizolid - authors' replyPhilippe Prokocimer, G Ralph Corey, Anita F Das, et al.
The American Journal of Tropical Medicine and Hygiene|July 29, 2009
Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapyNeela D Goswami, J Jina Shah, G Ralph Corey, et al.
Open Forum Infectious Diseases|December 18, 2015
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve EndocarditisJennifer A Johnson, Eoin R Feeney, David W Kubiak, et al.
Clinical Therapeutics|April 30, 2019
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE StudiesDavid B Huang, Stephanie Noviello, Barbara Balser, et al.
Pageof 18

Showing results (31-40 of 173) with videos related to

Sort By:
Pageof 18
Revista Da Sociedade Brasileira De Medicina Tropical|February 22, 2005
[Evaluation of a rapid test using recombinant k39 antigen in the diagnosis of visceral leishmaniasis in Brazil ]Elenice Moreira Lemos, Silvio F Guimarães Carvalho, Ralph Corey, et al.
The New England Journal of Medicine|March 7, 2008
Clinical problem-solving. A key miscommunication--an 81-year-old woman presented to the emergency department with increasing abdominal distention, nausea, and vomitingMelissa H Kong, G Ralph Corey, Thomas Bashore, et al.
Expert Opinion on Pharmacotherapy|November 15, 2011
Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumoniaEthan Rubinstein, G Ralph Corey, Martin E Stryjewski, et al.
Diagnostic Microbiology and Infectious Disease|July 23, 2013
Diagnostic dilemma in a returning traveler with feverJelena Catania, Seth S Martin, G Ralph Corey, et al.
The American Journal of Tropical Medicine and Hygiene|April 11, 2003
Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasisSilvio F Guimarães Carvalho, Elenice Moreira Lemos, Ralph Corey, et al.
American Heart Journal|April 13, 2004
Novel approaches to clinical trials: device-related infectionsRobert M Califf, Vance Fowler, Christopher H Cabell, et al.
The Lancet. Infectious Diseases|March 27, 2015
A closer inspection of tedizolid - authors' replyPhilippe Prokocimer, G Ralph Corey, Anita F Das, et al.
The American Journal of Tropical Medicine and Hygiene|July 29, 2009
Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapyNeela D Goswami, J Jina Shah, G Ralph Corey, et al.
Open Forum Infectious Diseases|December 18, 2015
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve EndocarditisJennifer A Johnson, Eoin R Feeney, David W Kubiak, et al.
Clinical Therapeutics|April 30, 2019
A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE StudiesDavid B Huang, Stephanie Noviello, Barbara Balser, et al.
Pageof 18